Edition:
India

People: Aquinox Pharmaceuticals Inc (AQXP.OQ)

AQXP.OQ on NASDAQ Stock Exchange Global Market

2.65USD
21 May 2019
Change (% chg)

$-0.05 (-1.85%)
Prev Close
$2.70
Open
$2.69
Day's High
$2.71
Day's Low
$2.65
Volume
12,780
Avg. Vol
16,288
52-wk High
$16.10
52-wk Low
$1.98

Alam, Kamran 

Mr. Kamran Alam is Chief Financial Officer, Vice President - Finance of the Company since August 2011. From June 2010 to August 2011, Mr. Alam served as Senior Director, Business Development of Sirius Genomics Inc., a biotechnology company. From October 2008 to June 2010, Mr. Alam served as Director, Business Development of the Centre for Drug Research and Development, a drug development and commercialization center. From January 2007 to October 2008, Mr. Alam served as Senior Manager, Business Development of Angiotech Pharmaceuticals, Inc., a pharmaceutical company. From 2004 to 2007, Mr. Alam served as Manager, Business Development of AnorMED Inc., a chemistry-based biopharmaceutical company. From 1998 to 2000, Mr. Alam worked in the life sciences practice group of PriceWaterhouseCoopers LLP, a global accounting and auditing firm where he obtained his Chartered Accountant designation, and gained valuable experience in the financing, auditing and tax structuring of a number of biotechnology and technology companies. Mr. Alam holds a B.Sc. in Cell Biology and Genetics from the University of British Columbia and an M.B.A. in International Business and Strategy from the University of Victoria and is a Chartered Accountant.

Basic Compensation

Total Annual Compensation, USD 181,080
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 303,737
Fiscal Year Total, USD 484,817

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --